Discover

Back to filter

Related topics

Cytek webinar : Evaluating Spectral Cytometry for Immune Profiling in Viral Disease

Cytek Biosciences

May 13, 2021

In conventional fluorescence cytometry, each fluorophore in a panel is measured in a...

Introducing ExoFlex - The latest assay for customized EV detection

NanoView Biosciences

May 11, 2021

ExoFlex allows users to customize the detection of EVs via any custom antibody. Nanoview...

Developing tools for multiplex to single EV analysis pipelines

Cytek Biosciences

May 10, 2021

Extracellular vesicles (EVs) are lipid spheres released from cells. EVs express proteins...

Single-cell DNA Analysis of a Novel Acute Erythroid Leukemia CRISPR Induced Mouse Model

Mission Bio

May 9, 2021

Assessment of precise genetic edits. Analysis of the clonal structure & co-mutations of AEL. Use of CRISPR and...

SARS-CoV-2 detection workflow in wastewater - Analytik Jena and project in Japan

Analytik Jena

May 8, 2021

In 2020 Analytik Jena real-time PCR thermal cyclers of the qTOWER³ series even supported one of the first SARS-CoV-2...

The impact of environmental Oxygen content on Natural Killer Cell Immunotherapy

Xcell Biosciences

May 7, 2021

Natural Killer (NK) cells are being studied in the clinic in a number of settings,...

Rethinking 3D cell culture with IncuCyte: advanced cell cultures from iPSCs and organoids

Sartorius

May 6, 2021

The world is neither flat nor two-dimensional, so why should cell culture be? Traditional...

Build your experiments online with new Spectrum Viewer and SpectroFlo Experiment Builder

Cytek Biosciences

May 5, 2021

Explore new capabilities of Cytek's Full Spectrum Viewer and complementary SpectroFlo...

Show all topics (10)

Optical radionuclide imaging strategies for preclinical studies

Apr 13, 2017

Preclinical imaging is a key step in a variety of scientific endeavors, including basic understanding of biological processes and pharmaceutical research and development. Two common classes of preclinical molecular imaging methods are (1) optical techniques, including fluorescence and bioluminescence, and (2) nuclear techniques, including PET, SPECT, as well as new optical imaging techniques discussed in this note. In many cases, the goal of preclinical molecular imaging is to look at the uptake, distribution, or interaction of a specific targeted molecule in vivo. These agents are typically referred to as probes or tracers in optical and nuclear imaging, respectively.
These agents are typically labeled or tagged with a distinguishing moiety in order to actively track them. However, fluorescent tags can be large relative to the target molecule of interest. On the other hand, radiolabeling typically has very little or no effect on the molecular shape, size, or function of a tagged molecule and many radionuclides can be directly incorporated into the native structure of the molecule of interest.

Read more

Scientific paper
Application

Brand profile

Bruker Biospin

Bruker is a performace leader in preclinical imaging instrumentation. Bruker offers nine imaging modalities: PET, SPECT, CT, MRI, MPI, fluorescence, luminiscence, radioisotipic imaging and X-ray.

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey